RxDoctor Payments Data

Jillian Hunt

Family · Cincinnati, OHNPI 1568744209

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $72,349 of the $115,739 with a category attached, or 62.5%. Merck accounts for 73.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $47,108 and has fallen 97.9% since, to $1,010 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,739in general payments, 2019–2025

Across 261 payments — averaging $443.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$85K
  • E.r. Squibb & Sons, L.L.C.$26K
  • Bristol Myers Squibb$3K
  • AstraZeneca$259
  • Sanofi-aventis U.S. LLC$249
  • Immunocore Limited$138
  • plus $998 from 21 others

What the payments were for

  • Consulting fees$7,4606%
  • Speaking & faculty fees$72,34963%
  • Travel & lodging$30,38026%
  • Food & beverage$5,2635%
  • Education$2870%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,739 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Other family in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →